article thumbnail

Why Boards Aren’t Dealing with Cyberthreats

Harvard Business

Methodology This survey was conducted through a partnership between Professor Boris Groysberg and Yo-Jud Cheng from Harvard Business School; WomenCorporateDirectors Foundation, led by Susan Stautberg; Spencer Stuart, led by Julie Hembrock Daum; and independent researcher Deborah Bell.

article thumbnail

So Many M&A Deals Fail Because Companies Overlook This Simple Strategy

Harvard Business

In the course of research for our book , we’ve found that this approach also provides an ideal methodology for leaders to identify which M&A deals are most likely to pay off — a disciplined approach that acts as a kind of lens for effectively distinguishing gold from iron pyrite in assessing potential company synergies.

Company 28
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Promise and Challenge of Big Data for Pharma

Harvard Business

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.

Data 28
article thumbnail

7 Charts Show How Political Affiliation Shapes U.S. Boards

Harvard Business

METHODOLOGY. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Maintaining a diversity of political perspectives is an important consideration to ensure that boards are equipped to anticipate and tackle the multitude of challenges that confront companies today.